Related Experiment Video
Updated: Aug 5, 2025

04:04
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
487
Electroacupuncture Alleviates Functional Constipation in Mice by Activating Enteric Glial Cell Autophagy via
Lu Wang1, Ying Chen1, Ming-Min Xu2
1Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
Chinese Journal of Integrative Medicine
|March 27, 2023
Summary
Electroacupuncture (EA) improves gastrointestinal motility in functional constipation (FC) mice by inhibiting the PI3K/AKT/mTOR pathway. This promotes enteric glial cell (EGC) autophagy, offering a novel therapeutic mechanism for FC.
Area of Science:
- Gastroenterology
- Autophagy Research
- Neurogastroenterology
Background:
- Functional constipation (FC) is a common disorder affecting gastrointestinal motility.
- Autophagy plays a role in regulating cellular functions, including those in the gut.
- Electroacupuncture (EA) is a potential therapeutic modality for gastrointestinal disorders.
Purpose of the Study:
- To elucidate the autophagy-related mechanisms underlying EA's efficacy in improving gastrointestinal motility in a mouse model of FC.
- To investigate the role of the PI3K/AKT/mTOR signaling pathway in EA's effects on FC.
Main Methods:
- A mouse model of functional constipation was established using diphenoxylate.
- Mice received EA stimulation at specific acupoints (Tianshu and Shangjuxu).
- Intestinal transit, colonic autophagy markers (LC3, Beclin-1), and the PI3K/AKT/mTOR pathway were assessed. The autophagy inhibitor 3-methyladenine (3-MA) was used to confirm EA's mechanism.
Main Results:
- EA significantly improved intestinal transit and fecal parameters in FC mice.
- EA upregulated autophagy markers LC3 and Beclin-1 in colonic tissues.
- EA inhibited the PI3K/AKT/mTOR signaling pathway and promoted autophagy in enteric glial cells (EGCs).
- The autophagy inhibitor 3-MA reversed the beneficial effects of EA.
Conclusions:
- EA treatment enhances gastrointestinal motility in FC mice by inhibiting the PI3K/AKT/mTOR pathway.
- This inhibition promotes autophagy in EGCs, representing a key mechanism for EA's therapeutic action.
- EA offers a promising therapeutic strategy for functional constipation through modulation of autophagy.

